PMID- 30014638 OWN - NLM STAT- MEDLINE DCOM- 20190212 LR - 20190215 IS - 1672-173X (Print) IS - 1672-173X (Linking) VI - 49 IP - 3 DP - 2018 May TI - [Effects of Thapsigargin on Intracellular Ca(2+) and Caspase-3 Protein Expression in Mouse Lung Fibroblast]. PG - 380-383 AB - OBJECTIVE: To explore the effects of calcium pump inhibitor thapsigargin (TG) on intracellular Ca(2+) and the expression of caspase-3 protein in mouse lung fibroblast. METHODS: Mice lung fibroblast cells were divided into three groups: the blank control group,transforming growth factor-beta(1) (TGF-beta(1)) group and TG treated group. The cells were induced by 5 ng/mL TGF-beta(1) for 24 h in TGF-beta(1) group and TG group,4 mumol/L TG was added in TG group for 24 h. After 48 h,the cells were collected,and the cell structure was observed by transmission electron microscope,intracellular Ca(2+) level was detected with laser confocal microscope,the protein expression of caspase-3 was examined using immunohistochemistry method. RESULTS: Transmission electron microscopy showed that the cells in the blank control group had obvious nucleolus,complete organelles and less apoptosis. In TGF-beta(1) group,the cell morphology was intact,chromatin was evenly distributed,and no apoptotic cells were found. In TG group,there were a large number of apoptosis of fibroblasts,chromatin clumps in nuclei and a small amount of collagen fibers. The level of Ca(2+) in TGF-beta(1) group was significantly lower than that in control group (P<0.05),and which in TG group was significantly higher (P<0.05 ). The protein expression of caspase-3 in TGF-beta(1) group were significantly lower than that in blank control group (P<0.05),which in TG group increased obviously (P<0.05). CONCLUSION: TG could cause intracellular calcium dysregulation in mouse lung fibroblasts,increase caspase-3 protein expression and promote cell apoptosis. CI - Copyright(c) by Editorial Board of Journal of Sichuan University (Medical Science Edition). FAU - Yan, Yu AU - Yan Y AD - College of Clinical Medicine,North China University of Science and Technology,Tangshan 063000,China. FAU - Xiao, Kun AU - Xiao K AD - College of Public Health,North China University of Science and Technology,Tangshan 063000,China. FAU - Liang, Xiao-Fei AU - Liang XF AD - College of Public Health,North China University of Science and Technology,Tangshan 063000,China. FAU - Zhang, Meng-Rou AU - Zhang MR AD - College of Clinical Medicine,North China University of Science and Technology,Tangshan 063000,China. FAU - Mao, Kai-Xuan AU - Mao KX AD - College of Clinical Medicine,North China University of Science and Technology,Tangshan 063000,China. FAU - Feng, Fan AU - Feng F AD - College of Clinical Medicine,North China University of Science and Technology,Tangshan 063000,China. FAU - Xiao, Yong-Hong AU - Xiao YH AD - College of Public Health,North China University of Science and Technology,Tangshan 063000,China. LA - chi PT - Journal Article PL - China TA - Sichuan Da Xue Xue Bao Yi Xue Ban JT - Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition JID - 101162609 RN - 0 (RNA, Messenger) RN - 0 (Transforming Growth Factor beta1) RN - 67526-95-8 (Thapsigargin) RN - EC 3.4.22.- (Casp3 protein, mouse) RN - EC 3.4.22.- (Caspase 3) RN - SY7Q814VUP (Calcium) SB - IM MH - Animals MH - Apoptosis MH - Calcium/metabolism MH - Caspase 3/*metabolism MH - Cells, Cultured MH - Fibroblasts/*drug effects MH - Lung/cytology MH - Mice MH - RNA, Messenger MH - Thapsigargin/*pharmacology MH - Transforming Growth Factor beta1/pharmacology OTO - NOTNLM OT - Calcium OT - Caspase-3 OT - Lung fibroblasts OT - Thapsigargin EDAT- 2018/07/18 06:00 MHDA- 2019/02/13 06:00 CRDT- 2018/07/18 06:00 PHST- 2018/07/18 06:00 [entrez] PHST- 2018/07/18 06:00 [pubmed] PHST- 2019/02/13 06:00 [medline] PST - ppublish SO - Sichuan Da Xue Xue Bao Yi Xue Ban. 2018 May;49(3):380-383.